AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 2 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $8,329,000 | +858.5% | 139,193 | +524.8% | 0.05% | +733.3% |
Q1 2019 | $869,000 | -70.9% | 22,277 | -84.1% | 0.01% | -71.4% |
Q4 2018 | $2,982,000 | +11.5% | 139,856 | +107.1% | 0.02% | +75.0% |
Q3 2018 | $2,674,000 | +90.2% | 67,544 | +83.6% | 0.01% | +100.0% |
Q2 2018 | $1,406,000 | -89.9% | 36,784 | -92.0% | 0.01% | -89.7% |
Q1 2018 | $13,887,000 | +1125.7% | 462,116 | +1174.8% | 0.06% | +1350.0% |
Q4 2017 | $1,133,000 | – | 36,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |